PDL Biopharma
PDLI
#8043
Rank
ยฃ0.20 B
Marketcap
ยฃ1.83
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Revenue for PDL Biopharma (PDLI)

Revenue in 2020 (TTM): ยฃ64.22 Million

According to PDL Biopharma 's latest financial reports the company's current revenue is ยฃ59.85 Million. In 2018 the company made a revenue of ยฃ0.14 Billion a decrease over the revenue in the year 2017 that were of ยฃ0.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PDL Biopharma from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ64.22 M
2018ยฃ0.14 B-35.24%
2017ยฃ0.22 B41.34%
2016ยฃ0.15 B-61.41%
2015ยฃ0.41 B1.67%
2014ยฃ0.40 B23.08%
2013ยฃ0.32 B18.26%
2012ยฃ0.27 B3.45%
2011ยฃ0.26 B4.95%
2010ยฃ0.25 B8.42%
2009ยฃ0.23 B8.13%
2008ยฃ0.21 B
2006ยฃ0.30 B48.05%
2005ยฃ0.20 B191.23%
2004ยฃ71.29 M32.84%
2003ยฃ53.67 M53.73%
2002ยฃ34.91 M5.97%
2001ยฃ32.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Compugen
CGEN
ยฃ5.12 M-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ26.70 B 44,519.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
ยฃ46.48 M-22.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.11 B 73,605.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ24.4 M-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA